Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
4 Apr 2012
UCB and Amgen Initiate Sclerostin Antibody Phase 3 program in patients with postmenopausal osteoporosis
Read More
3 Apr 2012
Neupro® approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome
Read More
29 Mar 2012
Acquisition of own shares in the framework of employees’ long-term incentive plans
Read More
22 Mar 2012
Acquisition of own shares
Read More
22 Mar 2012
New members on UCB's Board of Directors
Read More
20 Mar 2012
Transparency notification of Pharmahold SA
Read More
19 Mar 2012
Industry and academia join forces as UCB and Oxford University announce new R&D partnership
Read More
15 Mar 2012
Acquisition of own shares in the framework of employees’ long-term incentive plans
Read More
8 Mar 2012
Acquisition of own shares in the framework of employees’ long-term incentive plans
Read More
7 Mar 2012
UCB CEO to chair Innovative Medicines Initiative board
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
61
Page
62
Page
63
Page
64
Current page
65
Page
66
Page
67
Page
68
Page
69
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss